ARTICLE | Clinical News
Naloxone regulatory update
December 3, 2012 8:00 AM UTC
The European Commission granted Orphan Drug designation for Elorac's naloxone lotion to treat cutaneous T cell lymphoma (CTCL). Elorac plans to start Phase III testing of the opiate antagonist next ye...